138 related articles for article (PubMed ID: 15504545)
1. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG).
Wang JC; Hemavathy K; Charles W; Zhang H; Dua PK; Novetsky AD; Chang T; Wong C; Jabara M
Exp Hematol; 2004 Oct; 32(10):905-10. PubMed ID: 15504545
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO.
Chagraoui H; Tulliez M; Smayra T; Komura E; Giraudier S; Yun T; Lassau N; Vainchenker W; Wendling F
Blood; 2003 Apr; 101(8):2983-9. PubMed ID: 12506018
[TBL] [Abstract][Full Text] [Related]
3. Expression of osteoprotegerin mRNA and protein in murine megakaryocytes.
Chagraoui H; Sabri S; Capron C; Villeval JL; Vainchenker W; Wendling F
Exp Hematol; 2003 Nov; 31(11):1081-8. PubMed ID: 14585373
[TBL] [Abstract][Full Text] [Related]
4. Double mutations in klotho and osteoprotegerin gene loci rescued osteopetrotic phenotype.
Yamashita T; Okada S; Higashio K; Nabeshima Y; Noda M
Endocrinology; 2002 Dec; 143(12):4711-7. PubMed ID: 12446599
[TBL] [Abstract][Full Text] [Related]
5. Histomorphometric analysis of sclerotic bone from idiopathic myeloid metaplasia (nine cases).
Coindre JM; Reiffers J; Goussot JF; De Mascarel A; Broustet A
J Pathol; 1984 Nov; 144(3):163-9. PubMed ID: 6502295
[TBL] [Abstract][Full Text] [Related]
6. [Osteosclerosis and myelofibrosis].
Hadnagy C; Sass G; Kótay-Lakatos E; Izsák M; Borsai G
Med Klin; 1968 Nov; 63(48):1930-2. PubMed ID: 5710596
[No Abstract] [Full Text] [Related]
7. Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.
Rameshwar P; Chang VT; Thacker UF; Gascón P
Am J Hematol; 1998 Oct; 59(2):133-42. PubMed ID: 9766798
[TBL] [Abstract][Full Text] [Related]
8. [Blood coagulation studies in osteosclerosis and myelofibrosis].
Lakatos EK; Hadnagy C
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(3):365-8. PubMed ID: 4111760
[No Abstract] [Full Text] [Related]
9. [The shape of erythrocytes in patients with osteosclerosis-myelofibrosis and pernicious anemia].
Hadnagy C
Sangre (Barc); 1969; 14(4):421-6. PubMed ID: 5380221
[No Abstract] [Full Text] [Related]
10. Modulating OPG and TGF-β1 mRNA expression via bioelectrical stimulation.
Chaudhari SD; Sharma KK; Marchetto JJ; Hydren JR; Burton BM; Moreno AP
Bone Rep; 2021 Dec; 15():101141. PubMed ID: 34692946
[TBL] [Abstract][Full Text] [Related]
11. Acute monoblastic leukemia with osteosclerosis and extensive myelofibrosis.
Janin A; Nelken B; Dufour S; Sault MC; Taboureau O; Zandecki M; Gosselin B
Am J Pediatr Hematol Oncol; 1988; 10(4):319-22. PubMed ID: 3239709
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic myelofibrosis--an update with particular reference to clinical aspects and prognosis.
Hasselbalch HC
Int J Clin Lab Res; 1993; 23(3):124-38. PubMed ID: 8400333
[TBL] [Abstract][Full Text] [Related]
13. [Description of a case of idiopathic osteo-myelosclerotic anemia].
Masarone M
Pediatria (Napoli); 1970; 78(1):75-83. PubMed ID: 5422098
[No Abstract] [Full Text] [Related]
14. The role of interferon-alpha in the treatment of idiopathic myelofibrosis.
Bachleitner-Hofmann T; Gisslinger H
Ann Hematol; 1999 Dec; 78(12):533-8. PubMed ID: 10647876
[TBL] [Abstract][Full Text] [Related]
15. [Anatomo-clinical considerations on a case of so-called cryptogenetic myelosclerosis].
Natali G; Farello GE; Ventura T
Riv Anat Patol Oncol; 1967 Jun; 31(6):764-82. PubMed ID: 5621680
[No Abstract] [Full Text] [Related]
16. [Myelofibrosis and cryptogenetic osteosclerosis. A case of myelofibrosis with skin localizations, ascites and repeated hematemesis].
Gentili M
Policlinico Med; 1968; 75(1):1-33. PubMed ID: 5739279
[No Abstract] [Full Text] [Related]
17. [DIAGNOSIS OF MYELOFIBROSIS AND OSTEOMYELOSCLEROSIS].
PAPAGEORGIOU A
Dtsch Med Wochenschr; 1965 Mar; 90():436-7. PubMed ID: 14242203
[No Abstract] [Full Text] [Related]
18. [Study of erythrocyte survival in relation to the predominant sites of their destruction in patients with osteomyelosclerosis and myelofibrosis].
Sakhibov IaD; Aripov AIa
Ter Arkh; 1968 Apr; 40(4):92-7. PubMed ID: 5740515
[No Abstract] [Full Text] [Related]
19. Clinical and haematological improvement induced by etidronate in a patient with idiopathic myelofibrosis and osteosclerosis.
Sivera P; Cesano L; Guerrasio A; Camaschella C; Mazza U
Br J Haematol; 1994 Feb; 86(2):397-8. PubMed ID: 8199034
[TBL] [Abstract][Full Text] [Related]
20. [Cytochemical findings in terminal blastic crisis in osteomyelosclerosis].
Meister H
Acta Haematol; 1971; 46(5):307-17. PubMed ID: 4130948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
